Schiavoni, Elisa
 Distribuzione geografica
Continente #
EU - Europa 326
NA - Nord America 322
AS - Asia 66
AF - Africa 3
SA - Sud America 1
Totale 718
Nazione #
US - Stati Uniti d'America 318
IT - Italia 89
SE - Svezia 84
DE - Germania 52
FR - Francia 43
CN - Cina 39
IE - Irlanda 22
GB - Regno Unito 12
KR - Corea 8
FI - Finlandia 6
IN - India 5
IR - Iran 5
CA - Canada 4
TR - Turchia 4
JP - Giappone 3
PL - Polonia 3
PT - Portogallo 3
BE - Belgio 2
NL - Olanda 2
SG - Singapore 2
UA - Ucraina 2
AR - Argentina 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
HR - Croazia 1
HU - Ungheria 1
MK - Macedonia 1
NG - Nigeria 1
RO - Romania 1
RU - Federazione Russa 1
TN - Tunisia 1
Totale 718
Città #
Chandler 80
Ashburn 38
New York 26
Dublin 20
Milan 20
Rome 19
Marseille 17
Beijing 12
Princeton 8
Seoul 8
Boston 7
Jacksonville 7
Redmond 7
Bremen 6
Nürnberg 6
Paderno Dugnano 6
Houston 5
Nanjing 5
Wilmington 5
Cattolica 4
Dearborn 4
Lancaster 4
Pune 4
Atlanta 3
Chelsea 3
Helsinki 3
Izmir 3
Kunming 3
Lisbon 3
Redwood City 3
San Diego 3
San Mateo 3
Shanghai 3
Tianjin 3
Washington 3
Ann Arbor 2
Ardabil 2
Bentivoglio 2
Cagliari 2
Casarano 2
Cassino 2
Fairfield 2
Florence 2
Fremont 2
Hamilton 2
Hangzhou 2
Kish 2
Kraków 2
Lanzhou 2
Los Angeles 2
Naples 2
Olbia 2
Oristano 2
Paris 2
Saint-Fons 2
Seattle 2
Singapore 2
Waanrode 2
Abidjan 1
Arzachena 1
Augusta 1
Budapest 1
Busto Arsizio 1
Cambridge 1
Frankfurt am Main 1
Gdansk 1
Guangzhou 1
Hebei 1
Hefei 1
Hirakata 1
Iesi 1
Kocaeli 1
Lagos 1
Lappeenranta 1
Lawrence 1
Leawood 1
Mar Del Plata 1
Massa 1
Millbury 1
Montreal 1
Monza 1
Munich 1
Nabeul 1
Nanchang 1
North Billerica 1
Nuremberg 1
Sacramento 1
Shenyang 1
Tokyo 1
Toronto 1
Trieste 1
Vigevano 1
Zagreb 1
Zhengzhou 1
Totale 436
Nome #
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 124
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 121
Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease 88
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 56
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 49
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 44
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 43
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre 42
The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic 39
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 29
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 28
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 26
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study 21
The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19 14
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 5
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 4
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 2
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 2
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 2
Totale 739
Categoria #
all - tutte 3.405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.405


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 5 2
2019/202059 8 4 15 4 3 6 7 0 6 1 5 0
2020/202120 0 0 0 5 1 1 3 0 2 2 5 1
2021/202288 4 1 6 4 3 3 1 6 0 18 21 21
2022/2023276 44 32 11 35 20 17 28 27 27 6 11 18
2023/2024193 9 35 20 17 12 40 19 7 15 17 2 0
Totale 739